A potent human neutralizing antibody Fc-dependently reduces established HBV infections
Hepatitis B virus (HBV) infection is a major global health problem. Currently-available therapies are ineffective in curing chronic HBV infection. HBV and its satellite hepatitis D virus (HDV) infect hepatocytes via binding of the preS1 domain of its large envelope protein to sodium taurocholate cot...
| Հիմնական հեղինակներ: | , , , , , , , , , , , , , |
|---|---|
| Ձևաչափ: | Հոդված |
| Լեզու: | English |
| Հրապարակվել է: |
eLife Sciences Publications Ltd
2017-09-01
|
| Շարք: | eLife |
| Խորագրեր: | |
| Առցանց հասանելիություն: | https://elifesciences.org/articles/26738 |